$10M Avandia Fee Fight Correctly Resolved, Justices Told
By Alex Wolf ( January 5, 2016, 4:08 PM EST) -- The steering committee involved in centralized product-liability suits against GlaxoSmithKline LLC over diabetes drug Avandia has urged the U.S. Supreme Court to reject the Girardi Keese Law Firm's attempt to avoid paying $10 million in settlement money to a common benefit fund, saying the firm's case doesn't deserve the court's attention....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.